These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24449348)

  • 1. CD4/CD8 ratio is a promising candidate for non-invasive measurement of liver fibrosis in chronic HCV-monoinfected patients.
    Feuth T; van Baarle D; van Erpecum KJ; Siersema PD; Hoepelman AI; Arends JE
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1113-7. PubMed ID: 24449348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
    Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
    J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation.
    Vispo E; Barreiro P; Del Valle J; Maida I; de Ledinghen V; Quereda C; Moreno A; Macías J; Castera L; Pineda JA; Soriano V
    Antivir Ther; 2009; 14(2):187-93. PubMed ID: 19430093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
    de Lédinghen V; Barreiro P; Foucher J; Labarga P; Castéra L; Vispo ME; Bernard PH; Martin-Carbonero L; Neau D; García-Gascó P; Merrouche W; Soriano V
    J Viral Hepat; 2008 Jun; 15(6):427-33. PubMed ID: 18221303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection.
    Hartling HJ; Gaardbo JC; Ronit A; Knudsen LS; Ullum H; Vainer B; Clausen MR; Skogstrand K; Gerstoft J; Nielsen SD
    Scand J Immunol; 2012 Sep; 76(3):294-305. PubMed ID: 22671952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.
    Feuth T; Arends JE; Fransen JH; Nanlohy NM; van Erpecum KJ; Siersema PD; Hoepelman AI; van Baarle D
    PLoS One; 2013; 8(3):e59302. PubMed ID: 23555014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causative factors of liver fibrosis in HIV-infected patients. A single center study.
    Androutsakos T; Schina M; Pouliakis A; Kontos A; Sipsas N; Hatzis G
    BMC Gastroenterol; 2020 Apr; 20(1):91. PubMed ID: 32252653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity.
    Feuth T; Van Baarle D; Hoepelman AI; Van Erpecum KJ; Siersema PD; Arends JE
    Apoptosis; 2014 Jul; 19(7):1128-35. PubMed ID: 24752774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of liver fibrosis in monoinfected patients by hepatitis C virus and coinfected by HCV and human immunodeficiency virus.
    Tovo CV; Becker SC; Almeida PR; Galperim B; Chaves S
    Arq Gastroenterol; 2013; 50(1):19-22. PubMed ID: 23657302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.
    Williams SK; Donaldson E; Van der Kleij T; Dixon L; Fisher M; Tibble J; Gilleece Y; Klenerman P; Banham AH; Howard M; Webster DP
    J Viral Hepat; 2014 Apr; 21(4):251-9. PubMed ID: 24597693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
    Kirk GD; Astemborski J; Mehta SH; Spoler C; Fisher C; Allen D; Higgins Y; Moore RD; Afdhal N; Torbenson M; Sulkowski M; Thomas DL
    Clin Infect Dis; 2009 Apr; 48(7):963-72. PubMed ID: 19236273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy.
    Moustafa EF; Makhlouf N; Hassany SM; Helmy A; Nasr A; Othman M; Seif H; Darwish M; Hassan H; Hessen M
    Arab J Gastroenterol; 2017 Mar; 18(1):6-12. PubMed ID: 28262531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
    Schmid P; Bregenzer A; Huber M; Rauch A; Jochum W; Müllhaupt B; Vernazza P; Opravil M; Weber R;
    PLoS One; 2015; 10(9):e0138838. PubMed ID: 26418061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.